Home » Topics » BioWorld Science

BioWorld Science
RSS

Carna collaborates with Evotec to accelerate development of CB-1763

May 8, 2018

Polaris Pharmaceuticals creates new ADI-TRAIL fusion protein with antitumor activity

May 8, 2018

INTEREST study of Traumakine in ARDS does not meet primary efficacy composite endpoint

May 8, 2018

Takeda and Shire reach agreement on recommended offer for Shire

May 8, 2018

New trial explores use of AMO-01 in Phelan-McDermid syndrome

May 8, 2018

Aptose exercises option to license CrystalGenomics' CG-806

May 8, 2018

FDA approves Myrbetriq in combination with solifenacin for overactive bladder

May 8, 2018

QuANTUM-R study of quizartinib in FLT3-ITD-mutated AML meets primary endpoint

May 8, 2018

FDA approves Darzalex with VMP for newly diagnosed multiple myeloma

May 8, 2018

E.U. funding supports development of The Cell Factory's second-generation EV drug for stroke

May 8, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...